Forum partners

The modern, dynamically developing Russian pharmaceutical company, one of the leaders in the pharmaceutical industry of the Russian Federation in terms of growth rates. 

Skopinpharm is a developer and manufacturer of medicines, one of the leading suppliers under the program of 14 high-cost nosologies in accordance with the Ministry of Health of the Russian Federation orders. Skopinpharm offers a range of medications under the regional preferential insurance program, and is also one of the main suppliers of the Circle of Good Foundation for helping children with serious and life-threatening illnesses. The company's turnover amounted to more than 44.1 billion rubles by 2024.

The company operates in the following key areas: manufacture of plasma-derived medicinal products, cytostatics, and medicinal products used for the treatment of various oncological diseases. As part of developing these business areas, the company has constructed new manufacturing and storage buildings, performs technology transfer of unique pharmaceutical manufacturing processes, and has built a plasma storage facility with a laboratory unit, which will ensure proper storage of plasma intended for fractionation (raw materials for the manufacture of human plasma-derived medicinal products).

At the same time, in partnership with health authorities, a modern system for the procurement of blood plasma is being created and a voluntary donation program is being developed.

Skopinpharm actively supports the training and advanced training of pharmaceutical industry specialists and is one of the founders of the Academy of Good Practices of the EAEU.

Skopinpharm LLC

The address: Building 1, Industrial Zone No. 1, Skopin District, Ryazan Region, Russia, 391800.

info@skopinpharm.com

http://www.skopinpharm.com

Swixx BioPharma was founded to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE and beyond, that the multinational biopharma chooses not to enter, or to exit. With its expansion, Swixx BioPharma evolved into a professional and reliable partner with the highest standards in the areas where we operate.

At Swixx, we believe that everyone deserves access to the best medical solutions to live healthier and better lives. Although we are a pharmaceutical company without our own portfolio and research and development (R&D), we are committed to pursuing the standards and culture of a multinational pharmaceutical company.

We are highly experienced professionals, and our background is our strength. We joined forces and use our knowledge to constantly live up to our mission of providing access to the modern medicines of our partners.

EFKO is the largest Russian food company. The company specializes in the processing of oilseeds (sunflower, soybeans, and rapeseed), production of packaged oils, fats and oleo (special fat), mayonnaise and ketchup. The key trademarks are Sloboda, Pyshka, Altero, and Hi! (abbreviated "healthy innovation"). Production facilities located in the regions of Belgorod, Voronezh, Lipetsk, Sverdlovsk, Krasnodar Krai, as well as the Republic of Kazakhstan, are capable of processing over 4.5 million tons of oilseeds annually. The company actively diversifies its business through its own R&D centre, developing plant-based meat and milk under Hi! brand, and venture investments in food technology and biotechnology.

Brief information about the company Akrikhin:

JSC AKRIKHIN is one of Russia's leading pharmaceutical companies with almost 90 years of history, specializing in the production of effective, affordable and high-quality drugs in key therapeutic areas.

In terms of sales, the company is among the top 5 local pharmaceutical manufacturers on the Russian market and demonstrates stable growth rates.

The company's production site is located in Staraya Kupavna (Moscow Region) and has been operating since 1936. In recent years, the plant has undergone large-scale modernization, which has increased production capacity by 50%.

The company has its own R&D center (drug development center), focused on the creation of modern intelligent generics - new combinations and new dosage forms of existing drugs

The company's quality service has more than 90 specialists and provides control at every stage of production. Quality is one of the main priorities of Akrikhin.

The product portfolio includes more than 250 drugs, about 50% of which are included in the list of vital and essential drugs. Akrikhin annually brings about 10 new drugs to the market, actively participating in increasing the availability of therapy in Russia.

Petrovax Pharm is a Russian company prodicing novel biopharmaceutical practices, actively investing in scientific research and development.

The product portfolio includes original pharmaceutical products and vaccines, biotech drugs, and branded generics. The in-house R&D center for pre-clinical studies supports a full cycle of drug development.

The company's complex manufacturing for APIs and finished dosage forms is located in the Moscow region and operates in full compliance with the EAEU and EU GMP standards.

Petrovax is implementing international projects with leading pharmaceutical companies: Pfizer, Abbott, ISU ABXIS, Adimmune. The company is one of the largest Russian exporters of original medicines and vaccines to the countries of the EAEU and the EU.

Petrovax’s development strategy focuses on providing patients with novel vaccines and drugs for the prevention and treatment of infectious, oncological, and orphan diseases.

Company’s mission: Expanding access to cutting-edge therapies.

Pharmstandard Group of Companies is one of the leaders of the Russian Federation pharmaceutical market. The Groups prioritizes development and manufacture of advanced, high-quality and affordably priced drug products compliant with the healthcare requirements and patients’ expectations. The brand has been commercially available for over 20 years.

The Group's main manufacturing sites are located in the following Russian Federation regions: Pharmstandard-Leksredstva JSC in Kursk, Pharmstandard-UfaVITA JSC in Ufa, Pharmstandard- Tomskhimpharm JSC in Tomsk, and LEKKO CJSC in Volginsky settlement in the Vladimir region. Pharmstandard is engaged in the development of a modern complex intended for manufacturing solid dosage forms, Otisipharm Pro, near the city of Kaliningrad and owns a share in the authorized capital of Daliompharma, a processing donor human blood plasma company in the Republic of Belarus.

The pharmaceutical portfolio of Pharmstandard Group of Companies includes drugs used in ophthalmology, endocrinology and also for treatment of respiratory system, musculoskeletal system, oncological, hematological, cardiovascular, orphan, infectious and a number of other diseases. The products are available within the entire territory of Russia and abroad.

Today NIZHPHARM GROUP is one of the leading Russian manufacturers of high-quality pharmaceuticals with 105 years of history.

Our business pillars are:

CHC segment, including over-the-counter medicines, food supplements and medical devices.

Rx segment, including original medicine and generics.

Nizhpharm Group manages two manufacturing facilities: JSC Nizhpharm in Nizhny Novgorod and LLC Hemofarm in Obninsk, with a primary focus on serving patients and partners in the Russian market.

NIZHPHARM GROUP currently employs more than 2,200 people.

Our portfolio is a unique combination of locally produced essential medicines (60%) and products that we import to Russia (40%).

Day after day, we fulfill our purpose caring for people's health as a trusted partner by providing millions of patients with the essential medicines they need.